InteRNA Technologies and VU University Medical Center to Develop microRNA-based Diagnostics and Therapeutics for Cancer

03-Nov-2008 - InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announced the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA’s proprietary library of miRNAs. Under the research collaboration, ...

CNS-Diagnostics: Chimera Biotec Starts Study on Novel Biomarker Detection for Alzheimer's Disease

European Commission supports study including 11 centres from 6 European countries

13-Mar-2007 - Chimera Biotec joins the EU funded EDAR project to adapt the Imperacer(TM) platform technology for the detection of novel biomarkers for the diagnosis of Alzheimer's disease. The consortium wants to find out whether the new markers can be used to test efficacy of new drugs, thereby contributing ...

"RNAi Global" Accelerate Biomedical Discovery Using Genome-Wide siRNA Screening

Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi Global Initiative

17-Jul-2006 - The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc. and leading international research centers pioneering the use of whole-genome RNAi screening, today announced the addition of new members from Harvard Medical School, Stanford Medical School and the VU University ...